InvestorsHub Logo

Dr PeteRose MLB

04/04/14 4:12 PM

#101338 RE: Couch #101318

MRK is in no way interested in ELTP. I do know that is fact.

Steges

04/04/14 4:13 PM

#101339 RE: Couch #101318

Couch - That's is absolutely correct. Everyone in the industry looks at what happened to Pfizer with their ART/ADT attempts and is not willing to make the same mistake.

no2koolaid

04/04/14 4:49 PM

#101351 RE: Couch #101318

I appreciate your thoughts and in no way suggest a cheap takeover. With the experience of NH, he would approach the table as an equal and further the interest in the company. While I agree with your point about an ART launch generating a higher price, you must concede the point that it is a long held practice by big pharma to buy out a firm with drugs in the development stage. And, as I know you are aware, they do this because they may hold capabilities that would spur development and approval, enable manufacturing, further distribution, or all the above.